Literature DB >> 17193686

Kinetic analysis of hyaluronidase activity using a bioactive MRI contrast agent.

Liora Shiftan1, Michal Neeman.   

Abstract

One of the attractions of molecular imaging using 'smart' bioactive contrast agents is the ability to provide non-invasive data on the spatial and temporal changes in the distribution and expression patterns of specific enzymes. The tools developed for that aim could potentially also be developed for functional imaging of enzyme activity itself, through quantitative analysis of the rapid dynamics of enzymatic conversion of these contrast agents. High molecular weight hyaluronan, the natural substrate of hyaluronidase, is a major antiangiogenic constituent of the extracellular matrix. Degradation by hyaluronidase yields low molecular weight fragments, which are proangiogenic. A novel contrast material, HA-GdDTPA-beads, was designed to provide a substrate analog of hyaluronidase in which relaxivity changes are induced by enzymatic degradation. We show here a first-order kinetic analysis of the time-dependent increase in R(2) as a result of hyaluronidase activity. The changes in R(2) and the measured relaxivity of intact HA-GdDTPA-beads (r(2B)) and HA-GdDTPA fragments (r(2D)) were utilized for derivation of the temporal drop in concentration of GdDTPA in HA-GdDTPA-beads as the consequence of the release of HA-GdDTPA fragments. The rate of dissociation of HA-GdDTPA from the beads showed typical bell-shaped temperature dependence between 7 and 36 degrees C with peak activity at 25 degrees C. The tools developed here for quantitative dynamic analysis of hyaluronidase activity by MRI would allow the use of activation of HA-GdDTPA-beads for the determination of the role of hyaluronidase in altering the angiogenic microenvironment of tumor micro metastases. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17193686      PMCID: PMC4035508          DOI: 10.1002/cmmi.96

Source DB:  PubMed          Journal:  Contrast Media Mol Imaging        ISSN: 1555-4309            Impact factor:   3.161


  43 in total

1.  The application of 13C NMR to the characterization of phospholipid metabolism in cells.

Authors:  S M Ronen; H Degani
Journal:  Magn Reson Med       Date:  1992-06       Impact factor: 4.668

2.  Detection of exchange reactions involving small metabolite pools using NMR magnetization transfer techniques: relevance to subcellular compartmentation of creatine kinase.

Authors:  A P Koretsky; V J Basus; T L James; M P Klein; M W Weiner
Journal:  Magn Reson Med       Date:  1985-12       Impact factor: 4.668

3.  Magnetic resonance imaging visualization of hyaluronidase in ovarian carcinoma.

Authors:  Liora Shiftan; Tomer Israely; Miriam Cohen; Veronica Frydman; Hagit Dafni; Robert Stern; Michal Neeman
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

4.  The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer.

Authors:  Lishanthi Udabage; Gary R Brownlee; Susan K Nilsson; Tracey J Brown
Journal:  Exp Cell Res       Date:  2005-10-15       Impact factor: 3.905

5.  Lipid metabolism in large T47D human breast cancer spheroids: 31P- and 13C-NMR studies of choline and ethanolamine uptake.

Authors:  S M Ronen; E Rushkin; H Degani
Journal:  Biochim Biophys Acta       Date:  1992-03-20

6.  Lipid metabolism in T47D human breast cancer cells: 31P and 13C-NMR studies of choline and ethanolamine uptake.

Authors:  S M Ronen; E Rushkin; H Degani
Journal:  Biochim Biophys Acta       Date:  1991-10-16

7.  An ELISA-like assay for hyaluronidase and hyaluronidase inhibitors.

Authors:  M Stern; R Stern
Journal:  Matrix       Date:  1992-11

8.  Purification and characterization of human serum hyaluronidase.

Authors:  A M Afify; M Stern; M Guntenhöner; R Stern
Journal:  Arch Biochem Biophys       Date:  1993-09       Impact factor: 4.013

9.  Early estrogen-induced metabolic changes and their inhibition by actinomycin D and cycloheximide in human breast cancer cells: 31P and 13C NMR studies.

Authors:  M Neeman; H Degani
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  19F magnetic resonance spectroscopy studies of the metabolism of 5-fluorouracil in murine RIF-1 tumors and liver.

Authors:  P E Sijens; Y M Huang; N J Baldwin; T C Ng
Journal:  Cancer Res       Date:  1991-03-01       Impact factor: 12.701

View more
  8 in total

Review 1.  Molecular imaging and targeted therapies.

Authors:  David L Morse; Robert J Gillies
Journal:  Biochem Pharmacol       Date:  2010-04-21       Impact factor: 5.858

Review 2.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

Review 3.  Detecting enzyme activities with exogenous MRI contrast agents.

Authors:  Dina V Hingorani; Byunghee Yoo; Adam S Bernstein; Mark D Pagel
Journal:  Chemistry       Date:  2014-07-02       Impact factor: 5.236

Review 4.  Emerging roles for hyaluronidase in cancer metastasis and therapy.

Authors:  Caitlin O McAtee; Joseph J Barycki; Melanie A Simpson
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

5.  The Labeling, Visualization, and Quantification of Hyaluronan Distribution in Tumor-Bearing Mouse Using PET and MR Imaging.

Authors:  Wangxi Hai; Xiao Bao; Kang Sun; Biao Li; Jinliang Peng; Yuhong Xu
Journal:  Pharm Res       Date:  2020-11-04       Impact factor: 4.200

6.  Hyaluronidase activity of human Hyal1 requires active site acidic and tyrosine residues.

Authors:  Ling Zhang; Alamelu G Bharadwaj; Andrew Casper; Joel Barkley; Joseph J Barycki; Melanie A Simpson
Journal:  J Biol Chem       Date:  2009-02-06       Impact factor: 5.157

7.  Peritoneal adhesion and angiogenesis in ovarian carcinoma are inversely regulated by hyaluronan: the role of gonadotropins.

Authors:  Yael Chagit Tzuman; Stav Sapoznik; Dorit Granot; Nava Nevo; Michal Neeman
Journal:  Neoplasia       Date:  2010-01       Impact factor: 5.715

Review 8.  Imaging aspects of the tumor stroma with therapeutic implications.

Authors:  Lian Narunsky; Roni Oren; Filip Bochner; Michal Neeman
Journal:  Pharmacol Ther       Date:  2013-10-14       Impact factor: 12.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.